TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pharmaq AS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
1,551,274
|
1,224,407
|
1,175,896 |
Financial expenses |
80,018
|
78
|
1,458 |
Earnings before taxes |
772,656
|
544,020
|
611,979 |
Total assets |
2,834,967
|
2,149,577
|
1,749,035 |
Current assets |
2,411,007
|
1,649,945
|
1,297,039 |
Current liabilities |
390,571
|
276,785
|
289,535 |
Equity capital |
2,443,513
|
1,863,022
|
1,443,897 |
- share capital |
17,167
![]() |
17,167
![]() |
17,167 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
86.2%
|
86.7%
|
82.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
49.8%
|
44.4%
|
52.0% |
Return on assets (ROA) |
30.1%
|
25.3%
|
35.1% |
Current ratio |
617.3%
|
596.1%
|
448.0% |
Return on equity (ROE) |
31.6%
|
29.2%
|
42.4% |
Change turnover |
326,867
|
48,511
|
72,249 |
Change turnover % |
27%
|
4%
|
7% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.